🇺🇸 FDA
Pipeline program

Oral prednisolone (30mg/day) for 28 days

EDAHS111018

Approved small_molecule active

Quick answer

Oral prednisolone (30mg/day) for 28 days for Esophageal Neoplasms is a Approved program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Esophageal Neoplasms
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials